Prosecution Insights
Last updated: April 19, 2026

Examiner: MISHRA, DEEPA

Tech Center 1600 • Art Units: 1657

This examiner grants 31% of resolved cases

Performance Statistics

31.1%
Allow Rate
-28.9% vs TC avg
111
Total Applications
+33.4%
Interview Lift
1426
Avg Prosecution Days
Based on 74 resolved cases, 2023–2026

Rejection Statute Breakdown

6.7%
§101 Eligibility
11.7%
§102 Novelty
37.6%
§103 Obviousness
31.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17786149 ENZYME ENHANCED ROOT UPTAKE OF AGROCHEMICAL ACTIVE COMPOUND Final Rejection BASF SE
17910653 DETERMINATION OF FREE N-TERMINUS OF PEGFILGRASTIM USING AN ACID PROTEASE Non-Final OA AMGEN INC.
17789598 LIPASE-MODIFIED STRAIN Final Rejection DSM IP ASSETS B.V.
18001032 INORGANIC-BIOLOGICAL HYBRID SYSTEM FOR BIOFUEL PRODUCTION Non-Final OA Massachusetts Institute of Technology
17045605 GINGIVITIS DIAGNOSTIC METHODS, USES AND KITS Non-Final OA KONINKLIJKE PHILIPS N.V.
17437710 PROTEINS AND METHODS FOR DISRUPTING BACTERIAL COMMUNICATION Final Rejection REGENTS OF THE UNIVERSITY OF MINNESOTA
18222429 Determination of Hematocrit Non-Final OA IDEXX Laboratories, Inc.
18132514 Application of Strain CH18 in Preparation of Anthocyanins and Other Flavonoid Compounds Non-Final OA Beijing Institute of Technology
18691728 RECOMBINANT MICROORGANISM WITH CONTROLLED ABILITY TO PRODUCE POLYOLS OR EXOPOLYMERS Non-Final OA GS CALTEX CORPORATION
17316051 METHODS FOR THE IMPROVEMENT OF PRODUCT YIELD AND PRODUCTION IN A MICROORGANISM THROUGH THE ADDITION OF ALTERNATE ELECTRON ACCEPTORS Non-Final OA DANSTAR FERMENT AG
17413716 SACCHAROMYCES CEREVISIAE YEAST STRAIN FOR THE TREATMENT AND/OR PREVENTION OF OROPHARYNGEAL CANDIDIASIS Final Rejection LESAFFRE ET COMPAGNIE
17778569 METHOD FOR PREDICTING THE VIRULENCE AND PATHOGENICITY OF GRAM-NEGATIVE BACTERIAL STRAINS Non-Final OA UNIVERSITÉ PARIS-SACLAY
16348115 AUTOMATED METHOD FOR RELEASE OF NUCLEIC ACIDS FROM MICROBIAL SAMPLES Non-Final OA ZYMO RESEARCH CORPORATION
18251817 SPECIFIC SUBSTRATES AND PRODUCTS OF HSD17B13 AS MARKERS OF LIVER DISEASE AND BIOMARKERS FOR LIVER DISEASE TREATMENT Non-Final OA INIPHARM, INC.
18457679 RECOGNITION OF CELLULAR TARGET BINDING BY A BIOACTIVE AGENT USING INTRACELLULAR BIOLUMINESCENCE RESONANCE ENERGY TRANSFER Final Rejection Promega Corporation
18067158 METHOD FOR QUANTIFYING ETHANOLAMINE PHOSPHATE, OXIDOREDUCTASE FOR QUANTIFICATION, QUANTIFICATION COMPOSITION, QUANTIFICATION KIT, SENSOR CHIP, AND SENSOR Non-Final OA KIKKOMAN CORPORATION
18363407 SURFACE ACOUSTIC WAVE (SAW) 3D PRINTING METHOD Final Rejection AO TECHNOLOGY AG
17904339 METHOD FOR MANUFACTURING FIBER ASSEMBLY FOR PROVIDING BINDING SURFACE TO BIOSUBSTANCE AND FIBER ASSEMBLY, MANUFACTURED THEREBY, FOR PROVIDING BINDING SURFACE TO BIOSUBSTANCE Final Rejection AMOGREENTECH CO., LTD.
17635418 MICROCARRIERS FOR CELL CULTURE Final Rejection LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY (LIST)
18012440 ERYTHRITOL PRODUCING SAPROTROPH Final Rejection CONZIL ESTATE GMBH
17440371 NEW COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACNE VULGARIS Non-Final OA VAKONA AB
17107701 METHODS AND SYSTEMS FOR SAMPLE COLLECTION Final Rejection THORNE HEALTHCARE, INC.
17064826 INDIGENOUS AND IMPROVED FUNGALLY FERMENTED CBD, CBG AND RELATED CANNABINOID ORAL DOSAGE FORMS Final Rejection BYO Holdings, LLC
16871535 INDIGENOUS AND IMPROVED FUNGALLY FERMENTED CBD, CBG AND RELATED CANNABINOID ORAL DOSAGE FORMS Non-Final OA BYO Holdings, LLC
16931469 METHODS AND COMPOSITIONS FOR IMPROVING DETECTION OF MICROORGANISMS Non-Final OA BactoByte Ltd.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month